Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 3, 2009, Pages

  Schaier, Matthias ^a   Vorwalder, Stefanie ^a   Sommerer, Claudia ^a   Dikow, Ralf ^a   Hug, Friederike ^a   Gross, Marie Luise ^a   Waldherr, Rüdiger ^a   Zeier, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Inflammatory cell filtration

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; FINGOLIMOD; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GENE EXPRESSION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MACROPHAGE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SPRAGUE DAWLEY RAT;

EID: 69449106763     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90530.2008     Document Type: Article

References (62)

1. Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, Weller L, Grone HJ, Schlondorff D. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol 12: 919-931, 2001. (Pubitemid 32378332)
2. Anders HJ, Vielhauer V, Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003. (Pubitemid 36126787)
3. Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci USA 93: 12439-12444, 1996. (Pubitemid 26367162)
4. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14: 1835-1842, 2008.
5. Balatoni B, Storch MK, Swoboda EM, Schonborn V, Koziel A, Lambrou GN, Hiestand PC, Weissert R, Foster CA. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis. Brain Res Bull 74: 307-316, 2007. (Pubitemid 47368881)
6. Benigni A, Remuzzi G. How renal cytokines and growth factors contribute to renal disease progression. Am J Kidney Dis 37: S21-24, 2001. (Pubitemid 32048018)
7. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561, 1997. (Pubitemid 27514895)
8. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4: 1019-1025, 2004. (Pubitemid 38868590)
9. Brinkmann V, Lynch KR. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14: 569-575, 2002.
10. Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 54: 827-836, 1998. (Pubitemid 28397400)
11. Dev KK, Mullershausen F, Mattes H, Kuhn RR, Bilbe G, Hoyer D, Mir A. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol Ther 117: 77-93, 2008. (Pubitemid 350192672)
12. Dikow R, Becker L, Schaier M, Kihm LP, Gross ML. In renal transplants with delayed graft funktion (DGF) chemokines receptor expression predict longterm allograft function (Abstract). Am J Transplant 8: A233, 2008.
13. Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Remuzzi G, Zoja C. Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 36: 1226-1241, 2000.
14. Dragun D, Bohler T, Nieminen-Kelha M, Waiser J, Schneider W, Haller H, Luft FC, Budde K, Neumayer HH. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 65: 1076-1083, 2004. (Pubitemid 38251083)
15. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41: 297-309, 1992.
16. Fujihara CK, Malheiros DM, Zatz R, Noronha ID. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54: 1510-1519, 1998. (Pubitemid 28502893)
17. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2: 108-115, 2001.
18. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271: 17779-17784, 1996. (Pubitemid 26250752)
19. Goetzl EJ, Graler MH. Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes. J Leukoc Biol 76: 30-35, 2004.
20. Grone HJ, Weber C, Weber KS, Grone EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlondorff D, Nelson PJ. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 13: 1371-1383, 1999. (Pubitemid 29382505)
21. Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr Opin Nephrol Hypertens 7: 525-530, 1998. (Pubitemid 28475291)
22. Heller F, Lindenmeyer MT, Cohen CD, Brandt U, Draganovici D, Fischereder M, Kretzler M, Anders HJ, Sitter T, Mosberger I, Kerjaschki D, Regele H, Schlondorff D, Segerer S. The contribution of B cells to renal interstitial inflammation. Am J Pathol 170: 457-468, 2007. (Pubitemid 47339383)
23. Hershkoviz R, Alon R, Gilat D, Lider O. Activated T lymphocytes and macrophages secrete fibronectin which strongly supports cell adhesion. Cell Immunol 141: 352-361, 1992.
24. Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol 109: 134-142, 1997. (Pubitemid 27293895)
25. Kabashima K, Haynes NM, Xu Y, Nutt SL, Allende ML, Proia RL, Cyster JG. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J Exp Med 203: 2683-2690, 2006. (Pubitemid 44833344)
26. Kelley VR, Singer GG. The antigen presentation function of renal tubular epithelial cells. Exp Nephrol 1: 102-111, 1993.
27. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49: 666-678, 1996. (Pubitemid 26093075)
28. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 23: 842-852, 2008.
29. Kuroiwa T, Schlimgen R, Illei GG, McInnes IB, Boumpas DT. Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides. J Immunol 164: 3323-3329, 2000. (Pubitemid 30148997)
30. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006. (Pubitemid 43323069)
31. Magnotti RA Jr, Stephens GW, Rogers RK, Pesce AJ. Microplate measurement of urinary albumin and creatinine. Clin Chem 35: 1371-1375, 1989.
32. Main IW, Nikolic-Paterson DJ, Atkins RC. T cells and macrophages and their role in renal injury. Semin Nephrol 12: 395-407, 1992.
33. Martini S, Kramer S, Loof T, Wang-Rosenke Y, Daig U, Budde K, Neumayer HH, Peters H. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis. Am J Physiol Renal Physiol 292: F1761-F1770, 2007.
34. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360, 2004. (Pubitemid 38133663)
35. Muller-Krebs S, Kihm LP, Zeier B, Gross ML, Deppisch R, Wieslander A, Henle T, Penndorf I, Oh J, Reiser J, Nawroth PP, Zeier M, Schwenger V. Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure. Eur J Clin Invest 38: 296-305, 2008.
36. Nathan CF. Secretory products of macrophages. J Clin Invest 79: 319-326, 1987.
37. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, Suzuki H. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 16: 133-143, 2005. (Pubitemid 43073165)
38. Ota T, Tamura M, Osajima A, Doi Y, Kudo H, Anai H, Miyazaki M, Nishino T, Nakashima Y. Expression of monocyte chemoattractant protein-1 in proximal tubular epithelial cells in a rat model of progressive kidney failure. J Lab Clin Med 140: 43-51, 2002. (Pubitemid 34703346)
39. Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Kramer S, Neumayer HH. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Kidney Int 66: 1434-1443, 2004. (Pubitemid 39298375)
40. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984. (Pubitemid 14017051)
41. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 118: 3522-3530, 2008.
42. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 59: 1626-1640, 2001. (Pubitemid 32336778)
43. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55: 945-955, 1999. (Pubitemid 29100706)
44. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 278: 47281-47290, 2003. (Pubitemid 37452317)
45. Schaier M, Lehrke I, Schade K, Morath C, Shimizu F, Kawachi H, Grone HJ, Ritz E, Wagner J. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int 60: 2222-2234, 2001. (Pubitemid 33070465)
46. Schaier M, Liebler S, Schade K, Shimizu F, Kawachi H, Grone HJ, Chandraratna R, Ritz E, Wagner J. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med 82: 116-125, 2004. (Pubitemid 38299710)
47. Schiller B, Moran J. Focal glomerulosclerosis in the remnant kidney model - an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 12: 430-437, 1997. (Pubitemid 27105614)
48. Schlondorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 51: 610-621, 1997.
49. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 68: 437-455, 2005.
50. Segerer S, Banas B, Wornle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlondorff D, Grone HJ. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 164: 635-649, 2004. (Pubitemid 38364678)
51. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152-176, 2000. (Pubitemid 30020438)
52. Segerer S, Schlondorff D. Role of chemokines for the localization of leukocyte subsets in the kidney. Semin Nephrol 27: 260-274, 2007. (Pubitemid 46802915)
53. Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation 85: 15-21, 2008.
54. Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58: 1664-1676, 2000. (Pubitemid 30739671)
55. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95: 1370-1376, 1995.
56. Veniant M, Heudes D, Clozel JP, Bruneval P, Menard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int 46: 421-429, 1994. (Pubitemid 24253049)
57. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Grone HJ, Schlondorff D. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12: 1173-1187, 2001. (Pubitemid 32472630)
58. + cells in the progression of murine adriamycin nephropathy. Kidney Int 59: 941-949, 2001.
59. + T cells. Blood 97: 1144-1146, 2001.
60. Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008.
61. Zhang Z, Fauser U, Artelt M, Burnet M, Schluesener HJ. FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury. J Cell Mol Med 11: 307-314, 2007. (Pubitemid 46693329)
62. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp Neurol 210: 681-690, 2008.